Small-cap stocks, in general, are more domestic in nature, and this protects them from geopolitical and foreign exchange risks. Thus, small-cap stocks could offer relief to investors when there is uncertainty in the global market, like we are currently facing.
Another point in favor of small-cap stocks is that they have historically outperformed their large-cap peers over a long-term horizon. So, if you are also planning to invest in small-cap stocks, then to help you select, detailed below are the five best and worst performing small-cap stocks in Feb 2023.
Five Best Performing Small-Cap Stocks In Feb 2023
We have taken the February return data of small-cap stocks from finviz.com to develop this list of the five best and worst performing small-cap stocks in Feb 2023. We have used the market capitalization data as of March 1, 2023, to select the small-cap stocks. Here are the five best performing small-cap stocks in Feb 2023:
5. NGL Energy Partners (110%)
Founded in 1940, this company recycles and disposes water generated from the energy production process. NGL Energy Partners LP (NYSE:NGL) shares are up by over 184% year-to-date, bringing their one-year return to over 59%.
As of this writing, NGL Energy Partners shares are trading at above $3.80 with a 52-week range of $1.00 to $4.03, giving the company a market capitalization of more than $451 million.
4. Atlas Technical Consultants (118%)
Founded in 2017, this company offers professional testing, inspection engineering and consulting services. Atlas Technical Consultants Inc (NASDAQ:ATCX) shares are up by almost 136% year-to-date, bringing their one-year return to over 6%.
As of this writing, Atlas Technical Consultants shares are trading at above $12.10 with a 52-week range of $4.71 to $13.57, giving the company a market capitalization of more than $474 million.
3. Genelux (147%)
Founded in 2001, this company makes and markets drugs and virus strain solutions. As of this writing, Genelux Corp (NASDAQ:GNLX) shares are trading at above $22.30 with a 52-week range of $5.35 to $39.27, giving the company a market capitalization of more than $527 million.
2. SelectQuote (190%)
Founded in 1999, SelectQuote Inc (NYSE:SLQT) is an online platform that allows users to buy health, life, auto and home insurance policies. SelectQuote shares are up by almost 229% year-to-date, bringing their one-year return to over 9%.
As of this writing, SelectQuote shares are trading at above $2.20 with a 52-week range of $0.51 to $3.2492, giving the company a market capitalization of more than $367 million.
1. Ambrx Biopharma (230%)
Founded in 2033, it is a biopharmaceutical company that uses an expanded genetic code technology platform to develop Engineered Precision Biologics. Ambrx Biopharma Inc (NYSE:AMAM) shares are up by almost 327% year-to-date, bringing their one-year return to over 110%.
As of this writing, Ambrx Biopharma shares are trading at above $9.30 with a 52-week range of $0.38 to $13.07, giving the company a market capitalization of more than $374 million.
Five Worst Performing Small-Cap Stocks In Feb 2023
Here are the five worst performing small-cap stocks in Feb 2023:
5. Canoo (-46%)
Founded in 2018, this company makes electric vehicles. Canoo Inc (NASDAQ:GOEV) shares are down by almost 53% year-to-date, bringing their one-year return to almost -89%.
As of this writing, Canoo shares are trading at above $0.58 with a 52-week range of $0.5602 to $6.25, giving the company a market capitalization of more than $249 million.
4. Nektar Therapeutics (-47%)
Founded in 1990, this company discovers and develops medicines in areas of unmet medical need. Nektar Therapeutics (NASDAQ:NKTR) shares are down by over 47% year-to-date, bringing their one-year return to around -71%.
As of this writing, Nektar Therapeutics shares are trading at above $1.20 with a 52-week range of $1.1522 to $6.3950, giving the company a market capitalization of more than $225 million.
3. Fulcrum Therapeutics (-53%)
Founded in 2015, this company focuses on unlocking gene control mechanisms to develop small molecule therapies. Fulcrum Therapeutics Inc (NASDAQ:FULC) shares are down by over 38% year-to-date, bringing their one-year return to almost -71%.
As of this writing, Fulcrum Therapeutics shares are trading at above $4.50 with a 52-week range of $3.21 to $24.79, giving the company a market capitalization of more than $278 million.
2. FiscalNote Holdings (-54%)
Founded in 2013, it is a technology and data company that uses artificial intelligence, machine learning and other technologies. FiscalNote Holdings Inc (NYSE:NOTE) shares are down by almost 73% year-to-date, bringing their one-year return to almost -83%.
As of this writing, FiscalNote Holdings shares are trading at above $1.70 with a 52-week range of $1.71 to $12.30, giving the company a market capitalization of more than $226 million.
1. LanzaTech Global (-54%)
Founded in 2005, this company transforms waste carbon into materials. Lanzatech Global Inc (NASDAQ:LNZA) shares are down by over 68% year-to-date, bringing their one-year return to almost -68%.
As of this writing, LanzaTech Global shares are trading at above $3.10 with a 52-week range of $3.01 to $10.80, giving the company a market capitalization of more than $622 million.
This article originally appeared on ValueWalk
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
